Gladstone NOW: The Campaign Join Us on the Journey✕
Srivastava will present at the American Heart Association’s Scientific Sessions 2025 in New Orleans; the lectureship is a major recognition of excellence by the association.
Deepak Srivastava, MD, president of Gladstone Institutes and acclaimed cardiovascular scientist, has been chosen to deliver the American Heart Association’s Distinguished Scientist Lecture. Srivastava, who received the association’s highest honor of Distinguished Scientist in 2023, will present the featured lecture on cellular reprogramming in human disease at association’s Scientific Sessions 2025 in New Orleans on Saturday, Nov. 8.
“Heart disease remains one of humanity’s greatest challenges, but we now have the ability to repair and even replace what was once thought lost,” says Srivastava, who is also a senior investigator at Gladstone and director of the institute’s Roddenberry Stem Cell Center. “It’s a privilege to be selected to deliver this message to the world’s preeminent leaders and clinicians in cardiovascular medicine. These are the individuals whose work continues to redefine what’s possible for patients everywhere.”
Established in 2006, the Distinguished Scientist Lectureship is a major honor and recognition of excellence by the American Heart Association, with a single scientist selected annually.
Srivastava’s discoveries have transformed scientific understanding of the genetic and molecular mechanisms that drive heart development and disease, leading to innovative approaches for repairing heart damage and degeneration that are now advancing toward clinical trials.
Through his leadership at Gladstone, Srivastava is advancing innovation at the intersection of genetics, stem cell biology, and data science to accelerate new treatments for cardiovascular and other complex diseases. His research uncovered how scar-forming cells in the heart can be reprogrammed into beating heart cells, opening the door to novel approaches for heart failure, and his group revealed the genetic basis for many forms of congenital and acquired heart disease that are now being translated into real-world therapies for patients.
Among other notable achievements, Srivastava is an elected member of the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Association for the Advancement of Science. Srivastava also was named a 2024 Distinguished Citizen by Commonwealth Club World Affairs and recently was honored as Most Admired CEO by the San Francisco Business Times.
Kelly Quigley
Director, Science Communications and Media Relations
415.734.2690
Email
Gladstone Institutes is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease. Established in 1979, it is located in the epicenter of biomedical and technological innovation, in the Mission Bay neighborhood of San Francisco. Gladstone has created a research model that disrupts how science is done, funds big ideas, and attracts the brightest minds.
The featured scientists include global leaders in gene editing, data science, and immunology.
Awards News Release Corces Lab Doudna Lab Marson Lab Pollard Lab Ye LabThe striking findings of a new study could influence how gene therapies are designed for many genetic diseases.
News Release Research (Publication) Neurological Disease Conklin Lab Doudna Lab CRISPR/Gene EditingA new study from Gladstone Institutes strengthens the links between energy breakdown in cells and the onset of Parkinson’s, potentially illuminating new paths for treatment.
News Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab